0001646626-15-000004.txt : 20150708
0001646626-15-000004.hdr.sgml : 20150708
20150708171027
ACCESSION NUMBER: 0001646626-15-000004
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150708
DATE AS OF CHANGE: 20150708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chawla Lakhmir S
CENTRAL INDEX KEY: 0001646626
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 15979814
MAIL ADDRESS:
STREET 1: 1960 KIRBY ROAD
CITY: MCLEAN
STATE: VA
ZIP: 22101
3
1
wf-form3_143638981749746.xml
FORM 3
X0206
3
2015-07-01
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001646626
Chawla Lakhmir S
C/O LA JOLLA PHARMACEUTICAL COMPANY,
10182 TELESIS COURT, 6TH FLOOR
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
17.34
2025-02-06
Common Stock
60000.0
D
Represents an option to purchase a total of 60,000 shares of the Issuer's Common Stock previously issued pursuant to a consultancy arrangement. The option was fully vested with respect to one quarter of the underlying shares on the date of grant, with the remaining shares vesting quarterly thereafter over the next three years.
/s/ Chester S. Zygmont, III as attorney-in-fact for Lakhmir S. Chawla
2015-07-08